Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis

被引：10
|
作者：
Caleffi-Ferracioli, Katiany R. [1 ]
Cardoso, Rosilene F. [1 ]
de Souza, Joao V. P. [1 ]
Murase, Leticia S. [1 ]
Canezin, Pedro H. [1 ]
Scodro, Regiane B. L. [1 ]
Siqueira, Vera L. D. [1 ]
Pavan, Fernando R. [2 ]
机构：
[1] Univ Estadual Maringa, Dept Clin Anal & Biomed, Lab Med Bacteriol, Maringa, Parana, Brazil
[2] Univ Estadual Paulista, Sch Pharmaceut Sci, Dept Biol Sci, Sao Paulo, Brazil
来源：
FUTURE MICROBIOLOGY | 2019年 / 14卷 / 03期
基金：
巴西圣保罗研究基金会;
关键词：
efflux pump inhibitor; gene regulation; multidrug transporters; Mycobacterium tuberculosis; real-time PCR; resistance; rifampicin; synergism; tuberculosis; verapamil; ABC EFFLUX PUMP; DRUG-RESISTANCE; GENE-EXPRESSION; MECHANISMS; MUTATIONS;
D O I：
10.2217/fmb-2018-0277
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Aim: To evaluate modulatory effect of verapamil (VP) in rifampicin (RIF) activity and its effect in efflux pumps (EPs) transcript levels in Mycobacterium tuberculosis. Materials & methods: RIF and VP minimal inhibitory concentration, combinatory effect and detection of mutations were determined in 16 isolates. EPs transcript levels were determined in four isolates by real-time PCR after exposure to drugs. Results: VP showed good combinatory effect among RIF-resistant isolates. This effect was also observed in the relative transcript levels of EPs, mainly after 72h of exposure, depending on the EP gene, genotype and the resistance profile of the isolate. Conclusion: Additional regulatory mechanisms in the EP activities, as well as, interactions with other drug-specific resistance mechanisms need further investigation in M. tuberculosis.
引用
收藏
页码：185 / 194
页数：10
相关论文
共 50 条
  • [21] An Overview of Various Rifampicin Analogs against Mycobacterium tuberculosis and their Drug Interactions
    Asif, Mohammad
    Qusty, Naeem F.
    Alghamdi, Saad
    MEDICINAL CHEMISTRY, 2024, 20 (03) : 268 - 292
  • [22] Toxicity effects of AgZnO nanoparticles and rifampicin on Mycobacterium tuberculosis into the macrophage
    Jafari, Alireza
    Nodooshan, Saeedeh Jafari
    Safarkar, Roya
    Movahedzadeh, Farahnaz
    Mosavari, Nader
    Kashani, Aren Novin
    Dehghanpour, Mahdi
    Kamalzadeh, Morteza
    Koohi, Samira Rasouli
    Fathizadeh, Sara
    Majidpour, Ali
    JOURNAL OF BASIC MICROBIOLOGY, 2018, 58 (01) : 41 - 51
  • [23] Activity of β-lapachone derivatives against rifampicin-susceptible and -resistant strains of Mycobacterium tuberculosis
    Coelho, Tatiane S.
    Silva, Raphael S. F.
    Pinto, Antonio V.
    Pinto, Maria C. F. R.
    Scaini, Carlos J.
    Moura, Kelly C. G.
    da Silva, Pedro Almeida
    TUBERCULOSIS, 2010, 90 (05) : 293 - 297
  • [24] A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosis
    Unissa, Ameeruddin Nusrath
    Hanna, Luke Elizabeth
    Swaminathan, Soumya
    CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 87 (04) : 537 - 550
  • [25] SUSCEPTIBILITY OF RIFAMPICIN-ISONIAZID RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES AGAINST LEVOFLOXACIN
    Kurniawan, Alvin Hartanto
    Mertaniasih, Ni Made
    Soedarsono
    BALI MEDICAL JOURNAL, 2016, 5 (01) : 8 - 12
  • [26] A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis
    Lai, Li-Yin
    Hsu, Li-Yu
    Weng, Shang-Hui
    Chung, Shuo-En
    Ke, Hui-En
    Lin, Tzu-Lung
    Hsieh, Pei-Fang
    Lee, Wei-Ting
    Tsai, Hsing-Yuan
    Lin, Wan-Hsuan
    Jou, Ruwen
    Wang, Jin-Town
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [27] Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis
    dos Santos Fernandes, Guilherme Felipe
    de Souza, Paula Carolina
    Marino, Leonardo Biancolino
    Chegaev, Konstantin
    Guglielmo, Stefano
    Lazzarato, Loretta
    Fruttero, Roberta
    Chung, Man Chin
    Pavan, Fernando Rogerio
    dos Santos, Jean Leandro
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 123 : 523 - 531
  • [28] Evaluation of the Resistance of Mycobacterium tuberculosis to Rifampicin at the Regional Hospital Center of Maradi, Niger
    Abdoulaye, Ousmane
    Idi, Iklima Daibou
    Laouali, Harouna Amadou Mahaman
    Lawan, Ibrahim Maman
    Boureima, Hassane
    Mati, Fatima Guiet
    Biraima, Ahamadou
    Bacha, Boukar Sidi Maman
    Mamane, Saadou Habou
    Issa, Amoussa Gazaliou
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2022, 11 (04) : 412 - 414
  • [29] Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux
    Louw, Gail E.
    Warren, Robin M.
    Gey van Pittius, Nicolaas C.
    Leon, Rosalba
    Jimenez, Adelina
    Hernandez-Pando, Rogelio
    McEvoy, Christopher R. E.
    Grobbelaar, Melanie
    Murray, Megan
    van Helden, Paul D.
    Victor, Thomas C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (02) : 269 - 276
  • [30] Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?
    Ribeiro do Amaral, Renata Claro
    Caleffi-Ferracioli, Katiany Rizzieri
    Demitto, Fernanda de Oliveira
    de Almeida, Aryadne Larissa
    Dias Siqueira, Vera Lucia
    de Lima Scodro, Regiane Bertin
    Fujimura Leite, Clarice Queico
    Pavan, Fernando Rogerio
    Cardoso, Rosilene Fressatti
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 56 : 1 - 7
12345